Benzinga | Nov 5, 2021 09:32AM EDT

CytomX Therapeutics Q3 EPS $(0.35) Misses $(0.31) Estimate, Sales $17.59M Miss $18.08M Estimate

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.31) by 12.9 percent. This is a 9.37 percent decrease over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $17.59 million which missed the analyst consensus estimate of $18.08 million by 2.73 percent. This is a 1.13 percent decrease over sales of $17.79 million the same period last year.